Q&A: MLL's Alex Kohlmann on Targeted Diagnostic Sequencing of Leukemias
February 15, 2012
Q&A: MLL's Alex Kohlmann on Targeted Diagnostic Sequencing of Leukemias
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- IRON-II Study Uses 454 Sequencing to Investigate New Markers for Hematological Malignancies
September 12, 2012 / Clinical Sequencing News - MLL Developing RainDance, MiSeq Gene Panel for Myeloid Malignancies
August 15, 2012 / Clinical Sequencing News - Thermo Fisher Contacted Life Tech in 2011 about Possible Acquisition; Document Discloses Other Bidders
May 22, 2013 / GenomeWeb Daily News - NIH Team Presents Findings from Fungi-focused Study of Skin Microbiome
May 22, 2013 / GenomeWeb Daily News - Industry Observers Question Myriad's Competitive Advantage as It Looks to Launch NGS Cancer Panel
May 22, 2013 / Clinical Sequencing News